Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series.
about
Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Talimogene Laherparepvec combi ...... II-IV melanoma: a case series.
@en
Talimogene Laherparepvec combi ...... II-IV melanoma: a case series.
@nl
type
label
Talimogene Laherparepvec combi ...... II-IV melanoma: a case series.
@en
Talimogene Laherparepvec combi ...... II-IV melanoma: a case series.
@nl
prefLabel
Talimogene Laherparepvec combi ...... II-IV melanoma: a case series.
@en
Talimogene Laherparepvec combi ...... II-IV melanoma: a case series.
@nl
P2093
P2860
P1476
Talimogene Laherparepvec combi ...... II-IV melanoma: a case series.
@en
P2093
Brian Gastman
C Marcela Diaz-Montero
Charles Tannenbaum
Jennifer Ko
Jung Min Song
Lillian Sun
Michael Mcnamara
Patricia Rayman
Pauline Funchain
P2860
P2888
P356
10.1186/S40425-018-0337-7
P577
2018-05-16T00:00:00Z
P6179
1103934882